TAG ARCHIVES FOR clinical trials

8
Dec2012

by Rebecca Boxhorn, JD, Research Associate at the Consortium on Law and Values in Health, Environment & the Life Sciences at the University of Minnesota

The second day of the 2012 Advancing Ethical Research (AER) Conference got off to an engaging start thanks to the Keynote Address given by Dr. James R. Gavin III, executive vice president and chief medical officer [...] Read more

17
Oct2012

by Amy Davis, JD, MPH, Senior Director for Programs and Publications

PRIM&R recently sent comments to Congressman Edward Markey, (D-MA), senior member of the House Energy and Commerce Committee, on a bill called the Trial and Experimental Studies Transparency (TEST) Act of 2012. The goal of the bill is to increase transparency of clinical trials by expanding reporting [...] Read more

10
Aug2012

In this week’s Research Ethics Roundup, hear the latest developments in the H5N1 debate, explore one doctor’s plan to minimize research misconduct, and learn about a recent study that found that some physicians may be doing research for all the wrong reasons.

Private-sector physicians run clinical trials mostly for the money, study finds: There has been a dramatic shift in those conducting most clinical trials from academically-affiliated physicians to private-sector physicians. A new study suggests this shift might be the result of big money’s influence over medical research, with many doctors thinking of trials as business ventures rather than scientific endeavors. <[...] Read more

27
Jul2012

Recent changes to clinical trial rules in Europe, an emerging controversy over Food and Drug Administration (FDA)-approved anemia drugs, and heated debate over the bird flu moratorium are all in the mix in this week’s Research Ethics Roundup.

Europe proposes revision of clinical trial rules: The European Commission has formally adopted proposals for new rules to replace the controversial Clinical Trials Directive. Experts predict that these changes will reduce some of the red tape that has resulted in bloated insurance costs and a reduction in the number of clinical trials being conducted in the EU since the inception of the directive.

Page 8 of 9« First...56789